News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Dec 3, 2020 Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis Read Now
Publication May 10, 2020 Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease Read Now
Publication May 10, 2020 Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease Read Now
Publication May 10, 2020 Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid? Read Now
Publication May 10, 2020 Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study Read Now
